Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol 203(4):782–787
Ali RM, Ghonimy MB (2021) Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients. Egypt J Radiol Nucl Med 52(1):1–8
Al-Kuraishy HM, Al-Gareeb AI (2021) Acute kidney injury and COVID-19. Egypt J Intern Med 33(1):1–5
Al-Kuraishy HM, Al-Naimi MS, Lungnier CM, Al-Gareeb AI (2020a) Macrolides and COVID-19: an optimum premise. Biomed Biotechnol Res J 4(3):189
Al-Kuraishy HM, Al-Niemi MS, Hussain NR, Al-Gareeb AI, Al-Harchan NA, Al-Kurashi AH (2020b) The Potential Role of Renin Angiotensin System (RAS) and Dipeptidyl Peptidase-4 (DPP-4) in COVID-19: Navigating the Uncharted. In: Kibel A (ed) Selected chapters from the reninangiotensin system. IntechOpen, London, pp 151–165
Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Cruz-Martins N, Batiha GE (2021a) COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type II diabetes mellitus: the anti-inflammatory role of metformin. Front Med 8:110
Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE (2021b) The looming effects of estrogen in Covid-19: a rocky rollout. Front Nutr 8:649128
PubMed PubMed Central Article CAS Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Qusty N, Cruz-Martins N, Batiha GE (2021c) Sequential doxycycline and colchicine combination therapy in Covid-19: the salutary effects. Pulm Pharmacol Ther 67:102008
CAS PubMed PubMed Central Article Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE (2022) High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons. Inflammopharmacology 26:1
Al-kuraishy H, Al-Gareeb AI, Guerreiro SG, Cruz-Martins N, Batiha GE (2021d) COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med 8:335
Amarelle L, Quintela L, Hurtado J, Malacrida L (2021) Hyperoxia and lungs: what we have learned from animal models. Front Med 8:235
Aravamudhan A, Haak AJ, Choi KM, Meridew JA, Caporarello N, Jones DL, Tan Q, Ligresti G, Tschumperlin DJ (2020) TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation. Am J Physiol Lung Cell Mol Physiol 318(5):L852–L863
CAS PubMed PubMed Central Article Google Scholar
Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, Farrés J, Valls R, Fernandez-Fuentes N, de la Haba-Rodriguez J, Olvera A, Barbera J, Morales R (2020) In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm. PLoS One 15(10):e0240149
CAS PubMed PubMed Central Article Google Scholar
Balaramnavar VM, Ahmad K, Saeed M, Ahmad I, Kamal M, Jawed T (2020) Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro. RSC Adv 10(66):40264–40275
CAS PubMed PubMed Central Article Google Scholar
Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M (2020) Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 217(6): e20200652
CAS PubMed PubMed Central Article Google Scholar
Boopathy GT, Hong W (2019) Role of hippo pathway-YAP/TAZ signaling in angiogenesis. Front Cell Dev Biol 7:49
PubMed PubMed Central Article Google Scholar
Bridevaux PO, Aubert JD, Soccal PM, Mazza-Stalder J, Berutto C, Rochat T, Turin L, Van Belle S, Nicod L, Meylan P, Wagner G (2014) Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax 69(1):32–38
Carter NJ (2011) Pirfenidone Drugs 71(13):1721–1732
CAS PubMed Article Google Scholar
Chen Y, Zhao X, Sun J, Su W, Zhang L, Li Y, Liu Y, Zhang L, Lu Y, Shan H, Liang H (2019) YAP1/twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF. Cell Death Differ 26(9):1832–1844
CAS PubMed PubMed Central Article Google Scholar
Co JL, Badilles FA, Halun CB, Dy-Agra GN, Campomanes CM, Pagcatipunan RS, Divinagracia RM (2022) Pirfenidone for COVID-19 Associated Pulmonary Fibrosis: A Case Series. InC38. RARE AND COMMON ILDS: EPIDEMIOLOGY, DIAGNOSIS, AND MANAGEMENT 2022 May (pp. A4046-A4046). American Thoracic Society.
Combet M, Pavot A, Savale L, Humbert M, Monnet X (2020) Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19. Eur Respir J 56(2):2001808
CAS PubMed PubMed Central Article Google Scholar
Das KM, Lee EY, Singh R, Enani MA, Al Dossari K, Van Gorkom K, Larsson SG, Langer RD (2017) Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging 27(3):342
PubMed PubMed Central Article Google Scholar
Denney L, Branchett W, Gregory LG, Oliver RA, Lloyd CM (2018) Epithelial-derived TGF-β1 acts as a pro-viral factor in the lung during influenza A infection. Mucosal Immunol 11(2):523–535
CAS PubMed Article Google Scholar
Ferrara F, Granata G, Pelliccia C, La Porta R, Vitiello A (2020) The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2. Eur J Clin Pharmacol 76(11):1615–1618
CAS PubMed PubMed Central Article Google Scholar
Fila E, Rocco I, Rocco G, Zuccon U, Ruberti E (2021) Recommendations for the respiratory rehabilitation of hospitalized and discharged COVID-19 patients: a sistematic review. G Ital Med Lav Erg 43(1):56–65
Goda C, Balli D, Black M, Milewski D, Le T, Ustiyan V, Ren X, Kalinichenko VV, Kalin TV (2020) Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway. PLoS Genet 16(4):e1008692
CAS PubMed PubMed Central Article Google Scholar
Gokey JJ, Sridharan A, Xu Y, Green J, Carraro G, Stripp BR, Perl AK, Whitsett JA (2018) Active epithelial Hippo signaling in idiopathic pulmonary fibrosis. JCI Insight 3(6):e98738
PubMed Central Article Google Scholar
Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R (2021) Lung fibrosis: an undervalued finding in COVID-19 pathological series. Lancet Infect Dis 21(4):e72
CAS PubMed Article Google Scholar
Grimes JM, Grimes KV (2020) p38 MAPK inhibition: a promising therapeutic approach for COVID-19. J Mol Cell Cardiol 144:63–65
CAS PubMed PubMed Central Article Google Scholar
Gu Y, Cao J, Zhang X, Gao H, Wang Y, Wang J, Zhang J, Shen G, Jiang X, Yang J, Zheng X (2020) Interaction network of SARS-CoV-2 with host receptome through spike protein. https://doi.org/10.1101/2020.09.09.287508
Haak AJ, Kostallari E, Sicard D, Ligresti G, Choi KM, Caporarello N, Jones DL, Tan Q, Meridew J, Espinosa AM, Aravamudhan A (2019) Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. Sci Transl Med 11(516):eaau6296
CAS PubMed PubMed Central Article Google Scholar
Hamer M, Kivimäki M, Gale CR, Batty GD (2020) Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK. Brain Behav Immun 87:184–187
CAS PubMed PubMed Central Article Google Scholar
Johansson PI, Bestle M, Søe-Jensen P, Kristiansen KT, Stensballe J, Clausen NE, Perner A (2020) The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials 21:746
CAS PubMed PubMed Central Article Google Scholar
Kai H, Kai M (2020) Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res 43:648–654
CAS PubMed PubMed Central Article Google Scholar
Karamian A, Paktinat S, Esfandyari S, Nazarian H, Ziai SA, Zarnani AH, Salehpour S, Hosseinirad H, Karamian A, Novin MG (2021) Pyrvinium pamoate induces in-vitro suppression of IL-6 and IL-8 produced by human endometriotic stromal cells. Hum Exp Toxicol 40(4):649–660
CAS PubMed Article Google Scholar
Kayarat B, Khanna P, Sarkar S (2021) Pulmonary fibrosis in COVID-19 recovered patients: problem and potential management. Indian J Crit Care Med 25(2):242–244
CAS PubMed PubMed Central Article Google Scholar
Kayhan S, Kocakoç E (2020) Pulmonary fibrosis due to COVID-19 pneumonia. Korean J Radiol 21(11):1273
PubMed PubMed Central Article Google Scholar
Konigshoff M, Wilhelm A, Jahn A, Sedding D, Amarie OV, Eul B, Seeger W, Fink L, Gunther A, Eickelberg O, Rose F (2007) The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am J Respir Cell Mol Biol 37(6):640–650
PubMed Article CAS Google Scholar
Lancaster LH, de Andrade JA, Zibrak JD, Padilla ML, Albera C, Nathan SD, Wijsenbeek MS, Stauffer JL, Kirchgaessler KU, Costabel U (2017) Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis. Eur Respir Rev 26(146):170057
Latella G, Viscido A (2020) Could pirfenidone also be effective in treating intestinal fibrosis? Cells 9(8):1762
PubMed Central Article Google Scholar
Lee JH, Lim CM, Koh Y, Hong SB, Song JW, Huh JW (2020) High-flow nasal cannula oxygen therapy in idiopathic pulmonary fibrosis patients with respiratory failure. J Thorac Dis 12(3):966
留言 (0)